Fmoc-D-Cha-OHCAS# 144701-25-7 |
- PF-4708671
Catalog No.:BCC5031
CAS No.:1255517-76-0
- BIX 02565
Catalog No.:BCC4303
CAS No.:1311367-27-7
- BI-D1870
Catalog No.:BCC5030
CAS No.:501437-28-1
- CMK
Catalog No.:BCC1489
CAS No.:821794-90-5
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 144701-25-7 | SDF | Download SDF |
| PubChem ID | 978327 | Appearance | Powder |
| Formula | C24H27NO4 | M.Wt | 393.5 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (2R)-3-cyclohexyl-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid | ||
| SMILES | C1CCC(CC1)CC(C(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24 | ||
| Standard InChIKey | HIJAUEZBPWTKIV-JOCHJYFZSA-N | ||
| Standard InChI | InChI=1S/C24H27NO4/c26-23(27)22(14-16-8-2-1-3-9-16)25-24(28)29-15-21-19-12-6-4-10-17(19)18-11-5-7-13-20(18)21/h4-7,10-13,16,21-22H,1-3,8-9,14-15H2,(H,25,28)(H,26,27)/t22-/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Fmoc-D-Cha-OH Dilution Calculator
Fmoc-D-Cha-OH Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.5413 mL | 12.7065 mL | 25.413 mL | 50.8259 mL | 63.5324 mL |
| 5 mM | 0.5083 mL | 2.5413 mL | 5.0826 mL | 10.1652 mL | 12.7065 mL |
| 10 mM | 0.2541 mL | 1.2706 mL | 2.5413 mL | 5.0826 mL | 6.3532 mL |
| 50 mM | 0.0508 mL | 0.2541 mL | 0.5083 mL | 1.0165 mL | 1.2706 mL |
| 100 mM | 0.0254 mL | 0.1271 mL | 0.2541 mL | 0.5083 mL | 0.6353 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Fmoc-D-Cha-OH
- Hispidulin
Catalog No.:BCN6250
CAS No.:1447-88-7
- Olmesartan medoxomil
Catalog No.:BCC2143
CAS No.:144689-63-4
- Olmesartan
Catalog No.:BCC1819
CAS No.:144689-24-7
- (+)-Lyoniresinol
Catalog No.:BCN6248
CAS No.:14464-90-5
- 22-Hydroxy-3-oxoolean-12-en-29-oic acid
Catalog No.:BCN1565
CAS No.:144629-84-5
- GR 113808
Catalog No.:BCC7019
CAS No.:144625-51-4
- CPI-203
Catalog No.:BCC4099
CAS No.:1446144-04-2
- Isomahanine
Catalog No.:BCN3177
CAS No.:144606-95-1
- Schisanlignone D
Catalog No.:BCN3630
CAS No.:144606-84-8
- Schisanlignone C
Catalog No.:BCN3629
CAS No.:144606-83-7
- IRL-1038
Catalog No.:BCC5730
CAS No.:144602-02-8
- Paliperidone
Catalog No.:BCC3834
CAS No.:144598-75-4
- Telmisattan
Catalog No.:BCC3863
CAS No.:144701-48-4
- Telmisartan tert-butyl ester
Catalog No.:BCC9161
CAS No.:144702-26-1
- 4F 4PP oxalate
Catalog No.:BCC6678
CAS No.:144734-36-1
- 2-4-Hydroxy-3-methoxyphenyl-7-methoxy-5-benzofuranpropanol
Catalog No.:BCN1564
CAS No.:144735-57-9
- Cyclo(Phe-Val)
Catalog No.:BCN2419
CAS No.:14474-71-6
- Cyclo(Ala-Phe)
Catalog No.:BCN2411
CAS No.:14474-78-3
- Clopidogrel Related Compound B
Catalog No.:BCN2688
CAS No.:144750-52-7
- Brachynoside heptaacetate
Catalog No.:BCN6249
CAS No.:144765-80-0
- L-703,664 succinate
Catalog No.:BCC7437
CAS No.:144776-01-2
- 5-(4-(2-(5-Ethylpyridin-2-yl)ethoxy)benzylidene)thiazolidine-2,4-dione
Catalog No.:BCC8720
CAS No.:144809-28-9
- Deflazacort
Catalog No.:BCC8928
CAS No.:14484-47-0
- Alpiniaterpene A
Catalog No.:BCN7085
CAS No.:1448667-05-7
DR396, an apoptotic DNase gamma inhibitor, attenuates high mobility group box 1 release from apoptotic cells.[Pubmed:21167721]
Bioorg Med Chem. 2011 Jan 1;19(1):168-71.
High mobility group box1 (HMGB1) is a non-histone chromatin chromosomal protein playing an important role in chromatin architecture and transcriptional regulation. Recently, HMGB1 has been shown to be secreted into extracellular milieu in necrosis and apoptosis, and involved in inflammatory responses. However, the mechanism by which apoptotic cells release HMGB1 is unclear. In this study, to investigate the mechanism of HMGB1 release, we searched inhibitors of HMGB1 release from apoptotic cells. As a result, three compounds, 4-(4,6-dichloro-[1,3,5]-triazin-2-ylamino)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)-be nzoic acid (DR396), Pontacyl Violet 6R (PV6R), and Fmoc-D-Cha-OH (FDCO) in our in-house chemical library were found to inhibit HMGB1 release from staurosporine (STS)-induced apoptotic HeLa S3 cells. Interestingly, these three compounds have been previously categorized into apoptotic DNase gamma inhibitors. Therefore, we examined whether apoptotic nucleosomal DNA fragmentation is involved in the release of HMGB1 during apoptosis. Expectedly, DR396, which is the most potent and specific inhibitor of DNase gamma, was found to almost completely inhibit both HMGB1 release and internucleosomal DNA cleavage in HeLa S3 cells transfected with DNase gamma expression vector and stably expressing DNase gamma (HeLa S3/gamma cells). These results clearly suggest that nucleosomal DNA fragmentation catalyzed by DNase gamma is critical in the release of HMGB1 from apoptotic cells.
